Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO Injection in Pediatric Chronic ITP
CTR20190892Phase 2Completed
- Sponsor
- Shenyang Sansheng Pharmaceutical Co., Ltd.
- Start
- May 2019
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant human thrombopoietin in immune thrombocytopenic purpura (ITP), sponsored by Shenyang Sansheng Pharmaceutical Co., Ltd.. Started May 2019; status: completed.
02
Drugs
recombinant human thrombopoietin
03
Conditions
immune thrombocytopenic purpura (ITP)
Beyond the preview
Go deeper on CTR20190892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190892.